REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Innovelle Pharma Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Innovelle Pharma Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Innovelle Pharma Kft. is based in Hungary. The head office is in Budapest. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. It was first established on November 28, 2008. The total number of employees is currently 2 (2024). The company’s latest financial report indicates a net sales revenue drop of 1.25% in 2023. Its’ total assets recorded a growth of 16.81%. The net profit margin of Innovelle Pharma Kft. increased by 17.62% in 2023.

Headquarters
Dayka Gabor utca 3.
Budapest; Budapest; Postal Code: 1118

Contact Details: Purchase the Innovelle Pharma Kft. report to view the information.

Website: http://www.innowelle.hu

Basic Information
Total Employees:
Purchase the Innovelle Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Innovelle Pharma Kft. report to view the information.
Registered Capital:
Purchase the Innovelle Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Innovelle Pharma Kft. report to view the information.
Incorporation Date:
November 28, 2008
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Innovelle Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-1.25%▼
Total operating revenue
0.73%▲
Operating profit (EBIT)
344.57%▲
EBITDA
279.86%▲
Net Profit (Loss) for the Period
598.15%▲
Total assets
16.81%▲
Total equity
95%▲
Operating Profit Margin (ROS)
16.55%▲
Net Profit Margin
17.62%▲
Return on Equity (ROE)
43.78%▲
Quick Ratio
-9.11%▼
Cash Ratio
-1.53%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo